Andrea Engel joined Evonik’s Health Care business line in 2013 and is currently serving as Director Research & Development at Evonik Birmingham Laboratories focusing on Parenteral Drug Delivery, Biomaterials, and Medical Device applications. Prior to her current role, she was Head of Drug Delivery, supporting internal R&D efforts and customers in the development and analysis of new oral and parenteral platform technologies for the pharma, food industry, and cell culture industries. She received her degree in pharmacy from the University of Frankfurt am Main and her Ph.D. in pharmaceutical technology and biopharmacy from the University of Muenster, where she specialized in the development of drug delivery systems based on bioresorbable nanoparticles for cancer treatment. Furthermore, she holds an MBA degree from the Goethe Business School, Frankfurt. She has authored several research papers and patent applications.